U.S. stocks were lower, with the Dow Jones index falling around 350 points on Wednesday.
Shares of Gilead Sciences, Inc. GILD rose sharply during Wednesday's session after the company reported better-than-expected fourth-quarter financial results and issued FY25 adjusted EPS guidance above estimates.
Gilead Sciences reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $1.70. Quarterly revenue came in at $7.56 billion which beat the analyst consensus estimate of $7.13 billion and is an increase over revenue of $7.11 billion from the same period last year.
Gilead Sciences shares jumped 8.1% to $103.88 on Wednesday.
Here are some other big stocks recording gains in today's session.
- Upstart Holdings, Inc. UPST shares jumped 30.7% to $88.07 after the company reported better-than-expected fourth-quarter financial results and issued FY25 revenue guidance above estimates. Multiple analysts upgraded the stock following the report.
- AnaptysBio, Inc. ANAB rose 19.6% to $14.82 after the company announced statistically significant week 12 data from the Phase 2b trial of rosnilimab in moderate-to-severe rheumatoid arthritis.
- Mercury General Corporation MCY gained 17.4% to $58.80 after the company reported quarterly financial results. Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $70 to $80.
- EHang Holdings Limited EH rose 16.5% to $24.13.
- Confluent, Inc. CFLT gained 15.5% to $34.78 after the company reported better-than-expected fourth-quarter financial results.
- Angi Inc. ANGI surged 15% to $1.9850 following better-than-expected fourth-quarter sales and a year-over-year increase in EPS results.
- CVS Health Corporation CVS climbed 14.6% to $63.05 after the company reported quarterly earnings and revenue above estimates.
- Calumet, Inc. CLMT gained 13.3% to $18.00.
- The Chefs’ Warehouse, Inc. CHEF gained 11.3% to $60.69 following better-than-expected quarterly reported financial results.
- Sensata Technologies Holding plc ST surged 9.2% to $28.05 following a fourth-quarter adjusted EPS and revenue beat.
- iQIYI, Inc. IQ gained 9.2% to $2.50.
- VNET Group, Inc. VNET rose 8.5% to $10.82.
- CRISPR Therapeutics AG CRSP gained 8.4% to $42.95 after the company reported better-than-expected quarterly financial results and Barclays raised its price target on the stock from $55 to $56.
- Prudential plc PUK gained 6.1% to $18.10.
- IAC Inc. IAC surged 5.6% to $43.31 following strong quarterly sales.
Now Read This:
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.